Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery
NCT ID: NCT05583981
Last Updated: 2023-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
31 participants
OBSERVATIONAL
2021-12-01
2022-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Port Endoscopic Breast Conserving Surgery
NCT06593132
Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer
NCT00898131
Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer
NCT05158452
Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
NCT02125019
Implementation of a Web-based Decision Aid for Breast Cancer Surgery
NCT03304002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To identify and describe barriers to implementing breast Synoptic Operative Reports (SOR) from multiple constructs.
Ia. Identify performance objectives - who must do what - for the breast SOR to be adopted, implemented, and continued.
OUTLINE:
Participants participate in interview over 30-60 minutes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational (interview)
Participants participate in interview over 30-60 minutes.
Interview
Participate in interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interview
Participate in interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Available phone or device for contact
* English speaking
* Works at Commission on Cancer (CoC) - accredited cancer program
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Ohio State University Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ko Un Park
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ko Un Park, MD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University Comprehensive Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
The Jamesline
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2021-08725
Identifier Type: REGISTRY
Identifier Source: secondary_id
202010121
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
OSU-21198
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.